Robert Davis
| Robert Davis | |
| Nationality | American |
|---|---|
| Occupation | Business executive |
| Known for | Chairman and CEO of Merck & Co. |
Robert Davis is an American business executive who serves as the Chairman and Chief Executive Officer of Merck & Co., one of the largest pharmaceutical companies in the world. Under his leadership, Merck has continued to operate as a major force in the global healthcare and pharmaceutical industry. In 2026, Davis was named to the TIME TIME100 Health list, a recognition of his influence and impact in the health sector.[1] As the head of one of the world's foremost pharmaceutical enterprises, Davis oversees a company with a broad portfolio spanning oncology, vaccines, infectious diseases, and other therapeutic areas, continuing Merck's longstanding legacy in medical research and drug development.
Career
Leadership at Merck & Co.
Robert Davis serves as the Chairman and Chief Executive Officer of Merck & Co., a multinational pharmaceutical company headquartered in Rahway, New Jersey. Merck is one of the largest pharmaceutical companies by revenue globally, with operations in numerous countries and a portfolio that includes treatments and vaccines across a wide range of therapeutic areas.
As CEO, Davis has been responsible for guiding the strategic direction of the company, including its research and development pipeline, commercial operations, and global expansion efforts. Merck's portfolio under his tenure has included significant products in oncology, vaccines, hospital acute care, and other critical areas of medicine.
Recognition by TIME
In 2026, Robert Davis was included on the TIME100 Health list, an annual compilation by TIME magazine that highlights individuals considered to have significant influence in the field of health.[1] The recognition placed Davis among a select group of leaders, researchers, and advocates whose work has been identified as shaping the healthcare landscape. His inclusion on the list reflected his role at the helm of Merck and the company's contributions to global health initiatives, pharmaceutical development, and public health infrastructure.
Recognition
Davis's leadership at Merck & Co. has resulted in recognition from major media outlets and industry observers. His inclusion on the TIME100 Health 2026 list stands as a notable acknowledgment of his influence in the healthcare industry.[1] The TIME100 Health list is designed to spotlight individuals across healthcare — from executives and policymakers to scientists and advocates — who have made measurable contributions to the advancement of health outcomes worldwide. Davis's selection for the list reflects both his individual leadership and the broader impact of Merck's operations under his direction.
References
- ↑ 1.0 1.1 1.2 "Robert Davis".Time.2026.https://time.com/collections/time100-health-2026/7362458/robert-davis/.Retrieved 2026-02-23.